Global burden and gender disparity of vision loss associated with diabetes retinopathy. Issue 4 (29th October 2020)

• Record Type: Journal Article
• Authors: Xu, Yufeng; Wang, Aihong; Lin, Xiling; Xu, Jingya; Shan, Yi; Pan, Xiaowen; Ye, Juan; Shan, Peng‐Fei
• Is Part Of: Acta ophthalmologica. Volume 99:Issue 4(2021)
• Page Start: 431
• Page End: 440
• Publication Date: 2020-10-29
• Subjects: diabetic retinopathy -- disease burden -- gender disparity -- prevalence -- vision loss -- year lived with disability; Ophthalmology -- Periodicals; 617.7005
• DOI: 10.1111/aos.14644
• Languages: English
• ISSNs: 1755-375X

Abstract

Abstract: Purpose: To assess the trend patterns and gender disparity in global burden of vision loss due to diabetic retinopathy (DR) by year, age, region and socioeconomic status using prevalence and years lived with disability (YLDs) from Global Burden of Disease (GBD) study 2017. Methods: Prevalence and YLDs data of vision loss attributable to DR were extracted from GBD Study 2017 in 195 countries and territories. Socio‐demographic Index (SDI) in 2017 was cited as indicators of socioeconomic status. Kruskal–Wallis test, Dunn's multiple comparisons and Pearson linear correlation were adopted to evaluate the gender disparity and association with socioeconomic levels. Results: Globally, total age‐standardized prevalence and YLDs rates of vision loss due to DR peaked around 2005, with prevalence rate of 58.98 [95% uncertainty interval (UI) 50.95–68.56] and YLDs rate of 5.00 (95% UI 3.51–6.84) per 100 000 population, respectively. The burden were expected to increase to 65.74 (95% UI 60.14–70.86) and 5.68 (95% UI 4.07–7.22) by 2050. The burden would increase according to our projection based on current epidemiological situation. However, gender disparity has existed since 1990 and been enlarging in recent years, with female being more heavily impacted. This pattern remained with ageing among different stages of vision impairments and varied through GBD super regions. Gender difference (females minus males) of age‐standardized prevalence rates was positively related to SDI ( r = 0.1661, p = 0.0203). Diabetes has become a more important risk over the past 3 decades among the leading causes of vision loss. Conclusions: The DR‐related vision loss burden tended to increase under ageing population according to our projection with significant gender disparity. Public awareness of DR and gender sensitive health policy should be emphasized.